Prodotto aggiunto correttamente al carrello.

discount label
Ac-ATWLPPR-NH2
Visualizzare in 3D

Biosynth logo

Ac-ATWLPPR-NH2

Rif. 3D-PP46515

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Martedì 10 Dicembre 2024

Informazioni sul prodotto

Nome:
Ac-ATWLPPR-NH2
Sinonimi:
  • Ac-Ala-Thr-Trp-Leu-Pro-Pro-Arg-amide
Descrizione:

Peptide Ac-ATWLPPR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-ATWLPPR-NH2 include the following: Peptide-based siRNA delivery system for tumor vascular normalization and gene silencing in 4T1 cells Y Yi, C Feng, M Yu, L Mei, M Wu, W Tao - STAR protocols, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2666166723000965 The presence of PEG on nanoparticles presenting the c [RGDfK]-and/or ATWLPPR peptides deeply affects the RTKs-AKT-GSK3beta-eNOS signaling pathway and T Jia , J Ciccione, T Jacquet, M Maurel - International Journal of , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0378517319305496 Heteromultivalent targeting of integrin alphavbeta3 and neuropilin 1 promotes cell survival via the activation of the IGF-1/insulin receptors T Jia , J Choi, J Ciccione, M Henry, A Mehdi , J Martinez - Biomaterials, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961217306993 Definition of bifunctional theranostic molecules for cancer treatment T Jia - 2016 - hal.sciencehttps://hal.science/tel-01686187/ Selective targeting of verteporfin to choroidal neovascularization mediated by a homing peptide to VEGF-R2 R Renno, Y Terada, MJ Haddadin - & Visual Science, 2002 - iovs.arvojournals.orghttps://iovs.arvojournals.org/article.aspx?articleid=2421221 Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis R Binetruy-Tournaire, C Demangel , B Malavaud - The EMBO , 2000 - embopress.orghttps://www.embopress.org/doi/full/10.1093/emboj/19.7.1525 Transmembrane modification of tumor vascular targeting peptide A7R as molecular cargo delivery tool Q Zhang, Z Yang, J Zhang, Y Li, X Dang, J Qu - Bioorganic Chemistry, 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0045206824001457 Peptide-conjugated nanoparticles for photodynamic therapy P Couleaud, D Bechet, R Vanderesse - researchgate.nethttps://www.researchgate.net/profile/Regis-Vanderesse/publication/50601116_Nanoparticles_for_Photodynamic_Therapy_Applications/links/00b7d5310437cb78e3000000/Nanoparticles-for-Photodynamic-Therapy-Applications.pdf Photodynamic therapy targeting neuropilin-1: Interest of pseudopeptides with improved stability properties N Thomas, M Pernot, R Vanderesse, P Becuwe - Biochemical , 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006295210002455 Tissue distribution and pharmacokinetics of an ATWLPPR-conjugated chlorin-type photosensitizer targeting neuropilin-1 in glioma-bearing nude mice N Thomas, L Tirand, E Chatelut, F Plenat - Photochemical & , 2008 - Springerhttps://link.springer.com/article/10.1039/b718259g Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo N Thomas, D Bechet, P Becuwe, L Tirand - of Photochemistry and , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1011134409000669 Protease-resistant peptides for targeting and intracellular delivery of therapeutics MC Lucana, Y Arruga, E Petrachi, A Roig, R Lucchi - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/12/2065 Stability of peptides and therapeutic success in cancer M Pernot, R Vanderesse, C Frochot - Expert Opinion on , 2011 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1517/17425255.2011.574126 A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human L Tirand, C Frochot, R Vanderesse, N Thomas - Journal of Controlled , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365905006905 The neuropilin-1 inhibitor, ATWLPPR peptide, prevents experimental diabetes-induced retinal injury by preserving vascular integrity and decreasing oxidative stress J Wang, S Wang, M Li, D Wu, F Liu, R Yang, S Ji, A Ji - PLoS , 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0142571 A7RC peptide modified paclitaxel liposomes dually target breast cancer J Cao, R Wang, N Gao, M Li , X Tian, W Yang - Biomaterials , 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/bm/c5bm00161g Imaging Integrin alphavbeta3 and NRP-1 Positive Gliomas with a Novel Fluorine-18 Labeled RGD-ATWLPPR Heterodimeric Peptide Probe H Wu, H Chen , D Pan, Y Ma, S Liang, Y Wan - Molecular imaging and , 2014 - Springerhttps://link.springer.com/article/10.1007/s11307-014-0761-0 A7RC Peptide Modified Paclitaxel Liposomes Dually Target Breast Cancer H Peng, Q Wang - scholar.archive.orghttps://scholar.archive.org/work/d6hmly7vrjdynim2ift764inxm/access/wayback/http://pdfs.semanticscholar.org/b448/46abe293301f28a4282d75d67a8c4e806b5f.pdf Multifunctional peptide-conjugated hybrid silica nanoparticles for photodynamic therapy and MRI H Benachour , A Sacašve , T Bastogne , C Frochot - Theranostics, 2012 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475218/ In vitro evaluation and biodistribution of a 99mTc-labeled anti-VEGF peptide targeting neuropilin-1 GY Perret, A Starzec, N Hauet, J Vergote - Nuclear medicine and , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0969805104000290 Design of RGD-ATWLPPR peptide conjugates for the dual targeting of alpha V beta 3 integrin and neuropilin-1 F Thoreau , L Vanwonterghem, M Henry - Organic & , 2018 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2018/ob/c8ob00669e Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application EE Kamarulzaman, R Vanderesse - Journal of , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/07391102.2015.1131196 New peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1 for anti-vascular targeted photodynamic therapy EE Kamarulzaman, A Mohd Gazzali , S Acherar - International journal of , 2015 - mdpi.comhttps://www.mdpi.com/1422-0067/16/10/24059 Anti-tumor effects of a novel chimeric peptide on S180 and H22 xenografts bearing nude mice D Wu, Y Gao, L Chen, Y Qi, Q Kang, H Wang, L Zhu - Peptides, 2010 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978110000276 Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity D Tymecka, AK Puszko , PFJ Lipià „ski - European Journal of , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523418307566 Conjugation of Peptides to Antisense Interleukin-6 Via Click Chemistry CF Wang , S Auriola, J Hirvonen - Current Medicinal , 2014 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2014/00000021/00000010/art00007 Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1 A Starzec, R Vassy, A Martin, M Lecouvey - Life sciences, 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0024320506006084 of the antiangiogenic ATWLPPR peptide inhibiting VEGF165 binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex A Starzec, P Ladam, R Vassy, S Badache - Peptides, 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0196978107003853 neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex A Starzec, P Ladam, R Vassy, S Badache - 2007 - academia.eduhttps://www.academia.edu/download/49851582/Structure-function_analysis_of_the_antia20161025-23988-1obl1yo.pdf Optimization of multifunctional nanoparticles for improvements of photodynamic efficiency, tumor selectivity and MRI detection A Seve - 2013 - inis.iaea.orghttps://inis.iaea.org/search/search.aspx?orig_q=RN:54020364

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP46515 Ac-ATWLPPR-NH2

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".